Consensus statement by the American association of clinical endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm - 2015 executive summary

Alan J. Garber, Martin Julian Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Michael B. Davidson, Daniel Einhorn, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul David Rosenblit, Guillermo E. Umpierrez

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

Original languageEnglish
Pages (from-to)1403-1414
Number of pages12
JournalEndocrine Practice
Volume21
Issue number12
DOIs
StatePublished - Dec 2015

Fingerprint

Dive into the research topics of 'Consensus statement by the American association of clinical endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm - 2015 executive summary'. Together they form a unique fingerprint.

Cite this